Gonorrhea -- United Kingdom
A multidrug-resistant isolate of _Neisseria gonorrhoeae_ (see definition in ref 1) has been confirmed by the PHE Reference Laboratory as resistant to the current recommended dual 1st-line therapy (2). The isolate has a ceftriaxone MIC [minimum inhibitory concentration] of 0.5 mg/L and an azithromycin MIC greater than 256 mg/L (high-level azithromycin resistant, HLAziR). On wider antimicrobial susceptibility testing, the strain was susceptible only to spectinomycin. This is the 1st global
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?5719556&promed&0
No comments:
Post a Comment